REGESTRONE LX 40MG TABLET (28 TABLETS)
Form: Tablets
Pack Size: 28 TABLETS
Marketed by: TORRENT PHARMACEUTICALS LTD (ONCOLOGY DIV)
MRP: ₹2380.00
TORRENT PHARMACEUTICALS LTD (ONCOLOGY DIV): Regestrone LX 40MG Tablet (28 Tablets), 28 tablets, salt relugolix 40mg. Its MRP stays at Rs 2,380 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 1,813.33. Group: oral GnRH antagonist (hormone therapy). Same salt is also supplied by La Renon. Handling/counselling: check the strength: 120 mg is the prostate-cancer product. Schedule H - supply only to licensed buyers and dispense only on prescription.
Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.